- Home
- CRVO vs HPH Comparison
CRVO vs HPH Comparison
Compare CRVO & HPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- HPH
- Stock Information
- Founded
- CRVO 2001
- HPH 2010
- Country
- CRVO United States
- HPH China
- Employees
- CRVO N/A
- HPH N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- HPH
- Sector
- CRVO Health Care
- HPH
- Exchange
- CRVO Nasdaq
- HPH NYSE
- Market Cap
- CRVO 160.4M
- HPH 137.1M
- IPO Year
- CRVO N/A
- HPH 2019
- Fundamental
- Price
- CRVO $10.77
- HPH $0.34
- Analyst Decision
- CRVO Strong Buy
- HPH
- Analyst Count
- CRVO 5
- HPH 0
- Target Price
- CRVO $57.60
- HPH N/A
- AVG Volume (30 Days)
- CRVO 81.9K
- HPH 647.1K
- Earning Date
- CRVO 11-12-2024
- HPH 01-01-0001
- Dividend Yield
- CRVO N/A
- HPH N/A
- EPS Growth
- CRVO N/A
- HPH N/A
- EPS
- CRVO N/A
- HPH N/A
- Revenue
- CRVO $10,066,550.00
- HPH $286,996,105.00
- Revenue This Year
- CRVO $54.67
- HPH N/A
- Revenue Next Year
- CRVO N/A
- HPH N/A
- P/E Ratio
- CRVO N/A
- HPH N/A
- Revenue Growth
- CRVO 116.29
- HPH N/A
- 52 Week Low
- CRVO $5.85
- HPH $0.26
- 52 Week High
- CRVO $26.38
- HPH $10.06
- Technical
- Relative Strength Index (RSI)
- CRVO 33.46
- HPH 30.33
- Support Level
- CRVO $11.95
- HPH $0.26
- Resistance Level
- CRVO $12.35
- HPH $0.38
- Average True Range (ATR)
- CRVO 1.04
- HPH 0.05
- MACD
- CRVO -0.16
- HPH 0.02
- Stochastic Oscillator
- CRVO 7.45
- HPH 24.70
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About HPH HIGHEST PERFORMANCE HLDGS INC
Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. It focuses on providing personalized wealth management services for emerging middle-class and affluent families, comprehensive support services for financial planners, and diversified financial services for institutional clients.